Trade ZBIO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Zenas BioPharma, Inc. (ZBIO) is trading at US$23.85, down 4.75% today as of Nov 20, 16:00 EST. The company has a market capitalisation of US$1.72B. Over the past 52 weeks, ZBIO has traded between US$13.50 and US$44.60. On Syfe you can trade ZBIO with $0 commission and add it to your watchlist.
| Previous close | US$25.04 |
|---|---|
| Market cap | US$1.72B |
| 52-week range | US$13.50 – US$44.60 |
| Volume | 576.52K |
| Exchange | US |
Zenas BioPharma, Inc.
Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.
Year: 2024
Zenas BioPharma Reports New Obexelimab Data in IgG4-Related Disease
Oct 12, 11:38 AM · MT Newswires
Zenas BioPharma's Obexelimab Faces Larger IgG4-RD Opportunity, Wedbush Says
Sep 30, 3:33 PM · MT Newswires
--Earnings Flash (ZBIO) Zenas BioPharma Posts Q2 Loss $1.77 a Share, vs. FactSet Est of $1.12 Loss
Aug 13, 11:12 AM · MT Newswires
-- Earnings Flash (ZBIO) Zenas BioPharma, Inc. Reports Q2 Revenue $1.0M
Aug 13, 11:01 AM · MT Newswires
Zenas BioPharma, Inc. (ZBIO) stock is trading at US$23.85, -4.75% from the previous close of US$25.04.
The market cap for Zenas BioPharma, Inc. (ZBIO) stock is approximately US$1.72B.
The 52-week high for Zenas BioPharma, Inc. (ZBIO) stock is US$44.60.
The 52-week low for Zenas BioPharma, Inc. (ZBIO) stock is US$13.50.
Zenas BioPharma, Inc. (ZBIO) does not currently pay a dividend.
Stay on top of ZBIO
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore